View in EDS

First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study.

Saved in:
Bibliographic Details
Title: First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study.
Authors: Reck M; Airway Research Center North, German Center for Lung Research (DZL), LungenClinic, Grosshansdorf, Germany. Electronic address: m.reck@lungenclinic.de., Patel JD; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Gray JE; H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida., Reguart N; Hospital Clínic de Barcelona, Barcelona, Spain., Cobo M; Regional University Hospital, IBIMA. Plataforma BIONAND, Malaga, Spain., Pradera JF; Hospital Universitario Virgen de Valme, Seville, Spain., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cappuzzo F; Regina Elena Institute for Cancer Research, Rome, Italy., Garon EB; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Neal JW; Stanford Cancer Center, Stanford, California., Mekan S; Gilead Sciences, Inc., Foster City, California., Safavi F; Gilead Sciences, Inc., Foster City, California., Fernando N; Gilead Sciences, Inc., Foster City, California., Zavodovskaya M; Gilead Sciences, Inc., Foster City, California., Jürgensmeier JM; Gilead Sciences, Inc., Foster City, California., Chisamore M; Merck & Co., Inc., Rahway, New Jersey., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Mar; Vol. 21 (3), pp. 103509. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2025.10.016